Extracellular‐Matrix‐Based Materials from Decellularized Tissue: Opportunities, Challenges, and Future Directions in Regenerative Medicine
Advanced Healthcare Materials · 2026-01 · 15 (1)
DOI: 10.1002/adhm.202502107 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 17.11.2025. Verfasst von Madeline Laude und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, The University of Texas, Austin, TX, 78712, USA. Hauptthemen laut MEDLINE: Regenerative Medicine, Decellularized Extracellular Matrix, Biocompatible Materials, Extracellular Matrix. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology, Medical Research Council.
Abstract (Originalsprache)
Extracellular matrix (ECM) biomaterials have been used as inductive scaffolds to promote tissue regeneration in a variety of clinical applications. ECM biomaterials derived from decellularized tissue (dECM) can retain essential bioactive components of the native ECM that can guide cellular processes; however, the composition and bioactivity of the dECM is highly dependent on the decellularization and postprocessing methods. This intrinsic regenerative potential underpins the clinical success of dECM biomaterials in applications including soft tissue repair, cardiac reconstruction, and urological interventions. Here, clinical use of current dECM biomaterials, advances in the fabrication of dECM biomaterials, and hurdles to clinical translation of dECM products are discussed. Clinical use to date has mostly been limited to native dECM sheets or milling to generate powder dECM. Recent advances in fabrication methods from electrospinning to 3D printing have expanded the potential clinical applications of dECM biomaterials by increasing the structural and compositional complexity available to researchers. Despite significant progress, challenges remain in standardizing decellularization processes, optimizing dECM bioactivity retention, and ensuring mechanical compatibility with native tissues. Future research should focus on refining fabrication techniques and establishing standardized criteria for dECM characterization and translational pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, The University of Texas, Austin, TX, 78712, USA.
- Deparment of Bioengineering, Rice University, Houston, TX, 77005, USA.
- School of Pharmacy, The University of Nottingham, Nottingham, NG7 2RD, UK.
ORCID-Profile: Elizabeth Cosgriff-Hernandez
Förderung
- NCI NIH HHS
- Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology
- Medical Research Council
Zitieren
APA
Laude, M., Kolliopoulos, V., Mikos, A. G., White, L. J., & Cosgriff-Hernandez, E. (2026). Extracellular‐Matrix‐Based Materials from Decellularized Tissue: Opportunities, Challenges, and Future Directions in Regenerative Medicine. Advanced Healthcare Materials, 15(1). https://doi.org/10.1002/adhm.202502107
Vancouver
Laude M, Kolliopoulos V, Mikos AG, White LJ, Cosgriff-Hernandez E. Extracellular‐Matrix‐Based Materials from Decellularized Tissue: Opportunities, Challenges, and Future Directions in Regenerative Medicine. Advanced Healthcare Materials. 2026;15(1). doi:10.1002/adhm.202502107
BibTeX
@article{Laude2026,
author = {Laude, Madeline and Kolliopoulos, Vasiliki and Mikos, Antonios G and White, Lisa J and Cosgriff-Hernandez, Elizabeth},
title = {Extracellular‐Matrix‐Based Materials from Decellularized Tissue: Opportunities, Challenges, and Future Directions in Regenerative Medicine},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {1},
doi = {10.1002/adhm.202502107}
}
EUVIMED